by Gonzalo Payan | Sep 7, 2018
MAX BioPharma was recently selected into NIH’s Commercialization Accelerator Program (CAP). CAP is a highly competitive program that enables participants to establish market and customer relevance, build commercial relationships, and focus on revenue...by Gonzalo Payan | Sep 7, 2018
Available drug treatments for hair loss are modestly effective at best and often plagued by unpleasant side effects. In male pattern baldness, hormonal and other factors lead to a shortened growth (anagen) phase of the hair follicle, resulting in deactivated hair stem...by Gonzalo Payan | Jun 15, 2018
MAX BioPharma Awarded $1.7 Million to Fight Osteoporosis. For more details, follow this link to the LA Business Journalby Gonzalo Payan | Feb 21, 2018
MAX BioPharma participates in World Cancer Day. For more details, follow this link: MAX BioPharma participates in World Cancer Dayby Gonzalo Payan | Oct 28, 2016
MAX BioPharma Announces Key Updates on its Oxysterol Therapeutics™ Development Program, Intellectual Property Portfolio and Funding Initiatives...